EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A photoimmune synergizing RNA interference technology for highly effective antitumor treatment

Xiang Xia iD, Bingbing Wu, Xueze Zhao iD, Wen Sun iD, Jianjun Du iD, Jiangli Fan iD, Xiaojun Peng iD

Smart Molecules · 23.08.2026

DOI: 10.1002/smo2.70095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Smart Molecules, online erschienen am 23.08.2026. Verfasst von Xiang Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals Dalian University of Technology Dalian China. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photoimmunotherapy and RNA interference (RNAi) hold great potential for tumor therapy but exhibit limited efficacy as monotherapies. In this work, we report a red‐light‐activated combinatorial therapy that integrates photodynamic immunotherapy (PIT) with RNAi via a rationally designed photosensitizer, FNBS, developed on the basis of our previously reported advanced photosensitizer platform, HNBS. Upon cellular uptake and following red light irradiation, FNBS induces pyroptosis through the activation of nucleotide‐binding oligomerization domain‐like receptor thermal protein domain associated protein 3 inflammasome pathways, thereby enhancing antitumor immune responses and converting “cold” tumors into “hot” tumors. Meanwhile, ROS‐mediated oxidation of the furan moiety enables covalent RNA crosslinking and subsequent RNA degradation, thereby facilitating targeted RNAi. Owing to this dual mechanism, effective cancer cell elimination is achieved under normoxic (21% O 2 ) and hypoxic (2% O 2 ) conditions. FNBS has an IC 50 as low as 80 nM. In addition, RNA sequencing analysis reveals that FNBS‐induced cell death is closely associated with RNA‐related pathways, including RNA metabolism and RNA degradation. Collectively, this work establishes a novel combinatorial therapy strategy in which photodynamic therapy, immunotherapy, and RNA interference are integrated within a single small‐molecule platform, providing a foundation for achieving more effective cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

phenothiazine cationic photosensitizerphotoimmunotherapyphoto‐crosslinking‐mediated RNAi therapypyroptosistumor treatment

Autor:innen und Institutionen

  • State Key Laboratory of Fine Chemicals Dalian University of Technology Dalian China.
  • The Key Laboratory of Laboratory Medicine Ministry of Education School of Laboratory Medicine and Life Sciences Wenzhou Medical University Wenzhou China.

ORCID-Profile: Xiang Xia, Xueze Zhao, Wen Sun, Jianjun Du, Jiangli Fan, Xiaojun Peng

Zitieren

APA

Xia, X., Wu, B., Zhao, X., Sun, W., Du, J., Fan, J., & Peng, X. (2026). A photoimmune synergizing RNA interference technology for highly effective antitumor treatment. Smart Molecules. https://doi.org/10.1002/smo2.70095

Vancouver

Xia X, Wu B, Zhao X, Sun W, Du J, Fan J, et al. A photoimmune synergizing RNA interference technology for highly effective antitumor treatment. Smart Molecules. 2026. doi:10.1002/smo2.70095

BibTeX
@article{Xia2026,
  author = {Xia, Xiang and Wu, Bingbing and Zhao, Xueze and Sun, Wen and Du, Jianjun and Fan, Jiangli and Peng, Xiaojun},
  title = {A photoimmune synergizing RNA interference technology for highly effective antitumor treatment},
  journal = {Smart Molecules},
  year = {2026},
  doi = {10.1002/smo2.70095}
}
Kostenlos starten →